Metabolic Modulators in Heart Disease: Past, Present, and Future

Area of Science:

• Cardiology
• Metabolic Medicine
• Biochemistry

Background:

• Ischemic heart disease and heart failure are leading global causes of mortality and morbidity.
• Despite advances, these conditions remain a significant healthcare burden.
• Current treatments have limitations, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

• To review the role of metabolic modulation in treating ischemic heart disease and heart failure.
• To discuss past, present, and future therapeutic strategies involving metabolic modulators.
• To explore pharmacological interventions targeting myocardial energy substrate metabolism.

Main Methods:

• Review of existing literature on metabolic modulation in cardiac diseases.
• Analysis of alterations in myocardial energy substrate metabolism in heart failure and ischemic heart disease.
• Discussion of pharmacological targets for metabolic modulator therapy.

Main Results:

• Significant alterations in myocardial energy substrate metabolism, including shifts to glycolysis and uncoupling of glucose oxidation, contribute to cardiac inefficiency.
• Metabolic modulation, by optimizing energy substrate utilization, shows potential for improving cardiac efficiency.
• Targeting fatty acid and glucose oxidation pathways offers therapeutic avenues.

Conclusions:

• Metabolic modulation represents an underutilized but promising therapeutic approach for ischemic heart disease and heart failure.
• Optimizing myocardial energy substrate metabolism can improve cardiac efficiency and reduce disease severity.
• Pharmacological interventions targeting key metabolic enzymes hold potential for future treatments.